Skip to main content
Caplight Logo









Zoan BioMed

Zoan BioMed

Private
IrelandHealthcare & Life Scienceshttps://zoanbiomed.com/

Last Round

VC Round

May 3, 2022

Total Funding Raised

$2.53M

Company Overview

Zoan BioMed operates in Healthcare & Life Sciences and is based in Ireland. Its latest recorded funding round was a Seed round in December 2020.

Zoan BioMed is a biotechnology company that develops coral-derived bone graft therapies and orthobiologic scaffolds for orthopedic and surgical applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Advanced Materials, 3D Printing, Sustainable Materials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Zoan BioMed Comparables

Compare Zoan BioMed with similar companies based on industry and business-model similarity.

Zoan BioMed comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Marine Biomedical
84%
CoreBone
83%
Ossiform
81%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Zoan BioMed Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMay 3, 2022
SeedDec 1, 2020
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Zoan BioMed Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 3, 2022

    $5.25M round raised

  • Dec 1, 2020

    $2.5M raised from Enterprise Ireland and others.

Book a demo to see all signals

For institutional investors. Book with your work email.

Zoan BioMed Filings

Explore SEC and related filing metadata, where available.

Zoan BioMed filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Zoan BioMed's valuation, stock price, and market status.

Is Zoan BioMed a public or private company?

Zoan BioMed is a private company.

What is the current stock price of Zoan BioMed?

Zoan BioMed is a private company, so its shares have no public market price. Caplight tracks Zoan BioMed's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Zoan BioMed worth (valuation)?

Valuation information for Zoan BioMed is not publicly available.

Can I buy Zoan BioMed stock?

Zoan BioMed shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Zoan BioMed's last funding round?

Zoan BioMed's most recent funding round was VC Round on May 3, 2022.

Who are the main investors in Zoan BioMed?

Key investors in Zoan BioMed include Western Development Commission, EIT Health, Enterprise Ireland, Údarás na Gaeltachta.

Will Zoan BioMed IPO soon?

No public IPO plans have been announced for Zoan BioMed.

How can I track Zoan BioMed secondary market activity?

Caplight tracks bids, offers, and trades in Zoan BioMed's shares on secondary markets.

Firmographic Details

HeadquartersIreland
Employee Range3
Year Founded2016
Last FundingMay 3, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?